igf-1 lr3 human trial 1mg Recombinant Human LR3 IGF-I/IGF-1 GMP
Description
From the results of the survey, it appears the therapy is well tolerated with few reported side-effects
doi: 10.1111/j.1572-0241.2005.41583.x
10.7759/cureus.9639 232
In fact, one study found that muscle mass rose, but muscle strength declined in parallel [6]
Amer, A
Anal Bioanal Chem 404, 1813-22 (2012)
